S'abonner

Impact of Age and Race on Health-Related Quality of Life Outcomes in Patients Undergoing Radical Prostatectomy for Localized Prostate Cancer - 28/05/22

Doi : 10.1016/j.urology.2021.07.034 
Natasza Posielski 1, Jason Frankel 1, 2, Huai-Ching Kuo 3, 4, 5, On Ho 1, Sally Elsamanoudi 3, 4, Darryl Nousome 3, 4, 6, Ryan Speir 3, 7, Sean Stroup 3, 8, John Musser 3, 9, Alexander Ernest 3, 10, Gregory T. Chesnut 3, 11, Timothy Tausch 11, John Paul Flores 1, Christopher Porter 1,
1 Virginia Mason Franciscan Health, Seattle, WA 
2 Washington St. Louis University, St. Louis, MO 
3 Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 
4 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 
5 Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD 
6 Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD 
7 Madigan Army Medical Center, Tacoma, WA 
8 Naval Medical Center, San Diego, CA 
9 Tripler Army Medical Center, Honolulu, HI 
10 Brooke Army Medical Center, Fort Sam Houston, TX 
11 Walter Reed National Military Medical Center, Bethesda, MD 

Address correspondence to: Christopher Porter, MD, Medical Director, Clinical Research at Virginia Mason, Director, Urologic Oncology Fellowship, Co-Director, Urologic Oncology, Virginia Mason Medical Center, 1100 Ninth Ave., C7-URO, Seattle, WA, 98101.Medical Director, Clinical Research at Virginia Mason, Director, Urologic Oncology Fellowship, Co-Director, Urologic Oncology, Virginia Mason Medical Center1100 Ninth Ave., C7-UROSeattleWA98101

Abstract

Objectives

To investigate impact of age and race on health-related quality of life (HRQoL) in men undergoing radical prostatectomy (RP) using a prospectively maintained, racially diverse cohort.

Methods

The Center for Prostate Disease Research Multicenter National Database was used to identify patients receiving RP from 2007-2017. The Expanded PCa Index Composite and 36 Item Short-Form Health Survey were completed at baseline and regular intervals. Groups were stratified based on age: <60, 60-70, >70. Longitudinal patterns in HRQoL were assessed using linear regression models, adjusting for baseline HRQoL, demographics, and clinical characteristics.

Results

In 626 patients undergoing RP, 278 (44.4%) were <60, 291 (46.5%) were 60-70, 57 (9.1%) were >70. Older men had worse baseline urinary bother (P<.01) and sexual HRQoL (P<.01). Baseline urinary function was similar for older and younger men. Post-RP urinary and sexual HRQoL was significantly lower in men >70. However, when adjusting for baseline HRQoL, race, NCCN risk, and comorbidities, no difference was found between age groups in urinary function or bother, or sexual function. Sexual bother was worse in older men until 48 months post-operatively but subsequently improved to levels similar to younger patients. Race independently affected HRQoL outcomes with older African American men reporting worse urinary function and sexual bother.

Conclusions

When accounting for baseline HRQoL, age does not independently predict worse HRQoL outcomes. Older and younger men experience similar declines in urinary and sexual domain scores after RP. Our findings may be used to better inform patients regarding their expected post RP HRQoL and guide treatment decision-making.

Le texte complet de cet article est disponible en PDF.

Plan


 Disclosure: None.
 USU-DoD-HJF Disclaimer: The contents of this publication are the sole responsibility of the author(s) and do not necessarily reflect the views, opinions or policies of Uniformed Services University of the Health Sciences (USUHS), the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., the Department of Defense (DoD) or the Departments of the Army, Navy, or Air Force. Mention of trade names, commercial products, or organizations does not imply endorsement by the U.S. Government.


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 163

P. 99-106 - mai 2022 Retour au numéro
Article précédent Article précédent
  • Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer
  • Ashanda R. Esdaille, Christine Ibilibor, Arturo Holmes, Nynikka R. Palmer, Adam B. Murphy
| Article suivant Article suivant
  • EDITORIAL COMMENT
  • Amy N. Luckenbaugh

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.